The most frequently mutated genes in the chemo-naïve samples were well-established bladder cancer–associated genes: FGFR3 (70%), KMD6A (47%), PIK3CA (38%), KMT2D (26%), and ARID1A (23%). This evidence concerns the gene ARID1A and urinary bladder cancer.